Clinical Trial Detail

NCT ID NCT01916447
Title A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications

gastrointestinal system cancer

Therapies

Bevacizumab

trifluridine/tipiracil hydrochloride

Irinotecan

Age Groups: adult

No variant requirements are available.